A detailed history of Td Waterhouse Canada Inc. transactions in Novartis Ag stock. As of the latest transaction made, Td Waterhouse Canada Inc. holds 5,550 shares of NVS stock, worth $576,367. This represents 0.01% of its overall portfolio holdings.

Number of Shares
5,550
Previous 5,563 0.23%
Holding current value
$576,367
Previous $593 Million 7.6%
% of portfolio
0.01%
Previous 0.01%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$106.13 - $120.89 $1,379 - $1,571
-13 Reduced 0.23%
5,550 $638 Million
Q2 2024

Nov 12, 2024

SELL
$92.57 - $107.37 $40,082 - $46,491
-433 Reduced 7.22%
5,563 $593 Million
Q2 2024

Aug 02, 2024

BUY
$92.57 - $107.37 $1,851 - $2,147
20 Added 0.33%
5,996 $787 Million
Q1 2024

May 10, 2024

BUY
$95.27 - $108.47 $476 - $542
5 Added 0.08%
5,976 $590 Million
Q4 2023

Feb 12, 2024

SELL
$92.27 - $101.54 $98,544 - $108,444
-1,068 Reduced 15.17%
5,971 $655 Million
Q3 2023

Nov 13, 2023

SELL
$94.73 - $105.13 $38,555 - $42,787
-407 Reduced 5.47%
7,039 $746 Million
Q2 2023

Nov 13, 2023

BUY
$92.52 - $104.91 $7,956 - $9,022
86 Added 1.17%
7,446 $764 Million
Q1 2023

Nov 13, 2023

SELL
$80.03 - $92.81 $69,786 - $80,930
-872 Reduced 10.59%
7,360 $715 Million
Q4 2022

Nov 13, 2023

BUY
$75.55 - $92.52 $4,457 - $5,458
59 Added 0.72%
8,232 $797 Million
Q3 2022

Nov 13, 2023

SELL
$74.61 - $87.26 $169,812 - $198,603
-2,276 Reduced 21.78%
8,173 $658 Million
Q2 2022

Nov 13, 2023

BUY
$80.52 - $93.75 $170,219 - $198,187
2,114 Added 25.36%
10,449 $930 Million
Q1 2022

Nov 13, 2023

BUY
$80.11 - $90.62 $199,714 - $225,915
2,493 Added 42.67%
8,335 $763 Million
Q4 2021

Nov 13, 2023

BUY
$79.7 - $88.13 $465,607 - $514,855
5,842 New
5,842 $514 Million

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $223B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Td Waterhouse Canada Inc. Portfolio

Follow Td Waterhouse Canada Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Td Waterhouse Canada Inc., based on Form 13F filings with the SEC.

News

Stay updated on Td Waterhouse Canada Inc. with notifications on news.